Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

New Pediatric Labeling Information Database - Detail
  • Print
  • Share
  • E-mail
-
 
Pediatric Labeling Date:  12/16/2011
 
Trade Name:  Keppra
 
Generic Name or Proper Name (*):  levetiracetam
 
Indications Studied:  Adjunctive therapy in the treatment of partial onset seizures
 
Label Changes Summary:  Expanded indication to include pediatric patients from 1 month - <4 years; previously approved for use in 4 years and olderIn pediatric patients 1 month - < 4 years of age, 17% experienced psychotic symptoms compared to 5% on placebo; irritability was reported in 11.7% of the Keppra-treated patients compared to 0% of placebo patientsInformation on dosing, clinical trial, adverse reactions
 
Product Labeling:  Labeling  Opens a new window
 
BPCA(B) and PREA(P):  B, P
 
Sponsor:  UCB
 
Pediatric Exclusivity Granted Date:  06/03/2008
 
NNPS:  TRUE'
 
Therapeutic Category:  Anticonvulsant
 
-
-